Nisa Gregson, APRN
Family · Overland Park, KSNPI 1700308079
Payments from drug & device makers
Across 355 payments — averaging $15.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Pfizer$446
- Collegium Pharmaceutical, Inc.$437
- Forte Bio-pharma LLC$414
- Lundbeck LLC$260
- Scilex Pharmaceuticals Inc.$241
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,462100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 98 | $1,632 |
| Pfizer | 60 | $446 |
| Collegium Pharmaceutical, Inc. | 36 | $437 |
| Forte Bio-pharma LLC | 30 | $414 |
| Lundbeck LLC | 14 | $260 |
| Scilex Pharmaceuticals Inc. | 13 | $241 |
| GRT US Holding, Inc. | 15 | $231 |
| Amgen(2 entities) | 9 | $221 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $203 |
| Axsome Therapeutics, Inc. | 2 | $143 |
| Biohaven Pharmaceutical Holding Company Ltd. | 14 | $136 |
| Averitas Pharma Inc. | 4 | $112 |
| Upsher-smith Laboratories LLC | 4 | $98 |
| Indivior Inc. | 4 | $98 |
| Impel Pharmaceuticals Inc. | 5 | $93 |
| Protega Pharmaceutials Inc | 3 | $83 |
| Braeburn Inc. | 3 | $74 |
| Biodelivery Sciences International, Inc. | 4 | $57 |
| Almatica Pharma LLC | 2 | $55 |
| Biohaven Pharmaceuticals, Inc. | 3 | $52 |
| Eisai Inc. | 3 | $48 |
| Fidia Pharma USA Inc. | 2 | $43 |
| Arbor Pharmaceuticals, Inc. | 3 | $41 |
| Lilly USA, LLC | 2 | $38 |
| IBSA Pharma Inc. | 2 | $35 |
| International Rehabilitative Sciences, Inc | 2 | $28 |
| Si-bone, Inc. | 1 | $25 |
| Redhill Biopharma Inc. | 1 | $25 |
| Boston Scientific | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Merz Pharmaceuticals, LLC | 1 | $14 |
| Tonix Medicines, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Symbravo$122
How this compares
$5,462 in reported general payments places this provider in the 95th percentile of 1,579 family providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 293 | $31,427 |
| Buprenorphine | 87 | $25,292 |
| Xtampza ErOxycodone Myristate | 38 | $23,915 |
| OxycontinOxycodone Hcl | 38 | $21,868 |
| BelbucaBuprenorphine Hcl | 32 | $21,400 |
| Nurtec OdtRimegepant Sulfate | 15 | $21,195 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 618 | $16,728 |
| Nucynta ErTapentadol Hcl | 11 | $13,943 |
| MovantikNaloxegol Oxalate | 26 | $11,973 |
| Oxycodone Hcl | 657 | $10,848 |
| ZtlidoLidocaine | 11 | $10,254 |
| Aimovig AutoinjectorErenumab-Aooe | 13 | $9,617 |
| LinzessLinaclotide | 13 | $8,880 |
| Morphine Sulfate ErMorphine Sulfate | 329 | $7,574 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 45 | $6,163 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca, Nucynta Er | $437 | $59,25881 claims |
| PfizerNurtec Odt | $446 | $21,19515 claims |
| Redhill Biopharma Inc.Movantik | $25 | $11,97326 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $241 | $10,25411 claims |
| AbbVieLinzess | $1,632 | $8,88013 claims |
| Upsher-smith Laboratories LLCTopiramate | $98 | $2,560198 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,579 family providers in Kansas.
Other family in Overland Park
- Jennifer ChesterOverland Park$327K
- Erin FeitzOverland Park$36K
- Tracy GraebenerOverland Park$29K
- Kathryn TimmOverland Park$14K
- Lauren BarberOverland Park$12K
- Tracy HillOverland Park$8K
- Matthew NitschOverland Park$7K
- Gretchen PolandOverland Park$7K
- Anaya KoleOverland Park$7K
- Geneva BealOverland Park$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.